Literature DB >> 10714633

Inhibition of tyrosine kinase signaling after trauma-hemorrhage: a novel approach for improving organ function and decreasing susceptibility to subsequent sepsis.

D Jarrar1, P Wang, G Y Song, W G Cioffi, K I Bland, I H Chaudry.   

Abstract

OBJECTIVE: To determine whether administration of a tyrosine kinase inhibitor after trauma-hemorrhage has any beneficial effects on cardiovascular parameters and hepatocellular function and on survival rate after subsequent sepsis.
BACKGROUND: Increased inflammatory cytokine release and concomitant activation of intracellular signaling pathways contributes to multiple organ dysfunction and increased susceptibility to subsequent sepsis after severe hemorrhagic shock.
METHODS: Male Sprague-Dawley rats underwent a midline laparotomy (i.e., soft-tissue trauma induced) and were then bled to and maintained at a mean arterial pressure of 40 mmHg until 40% of the maximal shed blood volume was returned in the form of Ringer's lactate. The rats were then resuscitated with four times the shed blood volume in the form of Ringer's lactate during a 60-minute period. A tyrosine kinase inhibitor, AG 556 (7.5 mg/kg), or vehicle was administered intraperitoneally at the middle of resuscitation. At 24 hours after resuscitation, various in vivo parameters such as heart performance, cardiac index, and hepatocellular function (i.e., the maximum velocity and the overall efficiency of indocyanine green clearance) were determined. Phosphorylation state of the mitogen-activated protein kinases p44/42 and p38 in the liver was assessed by Western blot analysis. In additional groups of rats, sepsis was induced by cecal ligation and puncture at 20 hours after hemorrhage. The necrotic cecum was excised 10 hours thereafter, and the survival rate was monitored for a period of 10 days.
RESULTS: AG 556 treatment restored the depressed cardiovascular and hepatocellular functions after trauma-hemorrhage and resuscitation, which was associated with reduced phosphorylation of mitogen-activated protein kinases p44/42 and p38. Moreover, treatment with AG 556 significantly increased the survival rate of rats after trauma-hemorrhage and induction of subsequent sepsis compared with vehicle-treated rats.
CONCLUSION: Inhibition of tyrosine kinase signaling after trauma-hemorrhage may represent a novel therapeutic approach for improving organ functions and decreasing the death rate from subsequent sepsis under such conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10714633      PMCID: PMC1421011          DOI: 10.1097/00000658-200003000-00013

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  29 in total

1.  Hemorrhage activates myocardial NFkappaB and increases TNF-alpha in the heart.

Authors:  D R Meldrum; R Shenkar; B C Sheridan; B S Cain; E Abraham; A H Harken
Journal:  J Mol Cell Cardiol       Date:  1997-10       Impact factor: 5.000

2.  Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis.

Authors:  J E Sevransky; G Shaked; A Novogrodsky; A Levitzki; A Gazit; A Hoffman; R J Elin; Z M Quezado; B D Freeman; P Q Eichacker; R L Danner; S M Banks; J Bacher; M L Thomas; C Natanson
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

3.  Mechanism of adrenal insufficiency following trauma and severe hemorrhage: role of hepatic 11beta-hydroxysteroid dehydrogenase.

Authors:  P Wang; Z F Ba; D Jarrar; W G Cioffi; K I Bland; I H Chaudry
Journal:  Arch Surg       Date:  1999-04

4.  Both Erk and p38 kinases are necessary for cytokine gene transcription.

Authors:  A B Carter; M M Monick; G W Hunninghake
Journal:  Am J Respir Cell Mol Biol       Date:  1999-04       Impact factor: 6.914

5.  Pentoxifylline restores the depressed cardiac performance after trauma-hemorrhage and resuscitation.

Authors:  D A Robinson; P Wang; I H Chaudry
Journal:  J Surg Res       Date:  1996-11       Impact factor: 2.192

6.  Sphingosine blocks human polymorphonuclear leukocyte phagocytosis through inhibition of mitogen-activated protein kinase activation.

Authors:  E M Raeder; P J Mansfield; V Hinkovska-Galcheva; L Kjeldsen; J A Shayman; L A Boxer
Journal:  Blood       Date:  1999-01-15       Impact factor: 22.113

7.  Effect of sepsis on tissue adenine nucleotide levels.

Authors:  I H Chaudry; K A Wichterman; A E Baue
Journal:  Surgery       Date:  1979-02       Impact factor: 3.982

8.  Measurement of hepatocellular function, cardiac output, effective blood volume, and oxygen saturation in rats.

Authors:  J G Hauptman; G K DeJong; K A Blasko; I H Chaudry
Journal:  Am J Physiol       Date:  1989-08

9.  Outcome after hemorrhagic shock in trauma patients.

Authors:  S R Heckbert; N B Vedder; W Hoffman; R K Winn; L D Hudson; G J Jurkovich; M K Copass; J M Harlan; C L Rice; R V Maier
Journal:  J Trauma       Date:  1998-09

Review 10.  Tumor necrosis factor in the heart.

Authors:  D R Meldrum
Journal:  Am J Physiol       Date:  1998-03
View more
  6 in total

1.  A role of PPAR-gamma in androstenediol-mediated salutary effects on cardiac function following trauma-hemorrhage.

Authors:  Tomoharu Shimizu; László Szalay; Ya-Ching Hsieh; Takao Suzuki; Mashkoor A Choudhry; Kirby I Bland; Irshad H Chaudry
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

2.  Flutamide attenuates pro-inflammatory cytokine production and hepatic injury following trauma-hemorrhage via estrogen receptor-related pathway.

Authors:  Tomoharu Shimizu; Huang-Ping Yu; Ya-Ching Hsieh; Mashkoor A Choudhry; Takao Suzuki; Kirby I Bland; Irshad H Chaudry
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

3.  Tyrphostin AG 126 reduces intestinal ischemia-reperfusion injury in the rat.

Authors:  Stefania Marzocco; Emanuela Mazzon; Aldo Pinto; Giuseppina Autore; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-02-17       Impact factor: 3.000

4.  Mitogen-activated protein kinases in the intensive care unit: prognostic potential.

Authors:  Matthew R Rosengart; Avery B Nathens; Saman Arbabi; Margaret J Neff; Iris Garcia; Thomas R Martin; Ronald V Maier
Journal:  Ann Surg       Date:  2003-01       Impact factor: 12.969

5.  STAT3 mediates bone marrow mesenchymal stem cell VEGF production.

Authors:  Meijing Wang; Wenjun Zhang; Paul Crisostomo; Troy Markel; Kirstan K Meldrum; Xin Y Fu; Daniel R Meldrum
Journal:  J Mol Cell Cardiol       Date:  2007-04-24       Impact factor: 5.000

Review 6.  Inflammatory mediators in intra-abdominal sepsis or injury - a scoping review.

Authors:  Zhengwen Xiao; Crystal Wilson; Helen Lee Robertson; Derek J Roberts; Chad G Ball; Craig N Jenne; Andrew W Kirkpatrick
Journal:  Crit Care       Date:  2015-10-27       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.